CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Giredestrant

Phase 3
Roche Holding AG (RHHBY)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
RHHBYPhase 2

Giredestrant Phase 2 Est. Readout

Giredestrant
Aug 2026~
CT.gov
00%
Drug Information

Target Indication

Endometrial Cancer

Clinical Trial

NCT05634499

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.